Published May 2022 | 9 Pages | 5 Exhibits | Forecasts Through 2026
This report from Life Science Intelligence provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hyperplasia (BPH). Implants are a temporary or permanent solution for men suffering from symptoms caused by prostate enlargement. LSI projects that this market will thrive throughout the forecast period as these devices become more accessible to men seeking relief from BPH.
This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into:
BD
Boston Scientific
Endotherapeutics
Fabian
Olympus
ProArc
ProVerum
Teleflex
ZenFlow
We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500
Huntington Beach, CA 92647
© 2024 Life Science Intelligence, Inc., All Rights Reserved.